Upregulation of Toll-Like Receptors (TLRs) 6, 7, and 8 in Keloid Scars  by Bagabir, Rania A. et al.
Upregulation of Toll-Like Receptors (TLRs) 6, 7, and 8 in
Keloid Scars
Journal of Investigative Dermatology (2011) 131, 2128–2130; doi:10.1038/jid.2011.163; published online 16 June 2011
TO THE EDITOR
Keloid scar (KS) is a benign fibro-
proliferative dermal tumor of unknown
origin that develops in genetically
susceptible individuals (Shih and Bayat,
2009). KS commonly occurs following
trauma to the skin, which is likely to
facilitate inoculation of infectious
agents. Interestingly, it has been repeat-
edly observed that KS develops after
clinical evidence of viral infection,
such as chicken pox (Gathse et al.,
2003) and zoster (Manikhas et al.,
1986; Koley et al., 2009). In addition,
it has been reported that some skin
tumors such as Merkel cell carcinoma
are associated with viruses (Masahiro
et al., 2009). On this basis, it has been
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Figure 1. Toll-like receptor (TLR) protein expression in keloid scar in situ. Quantitative immunohistochemistry of expression of TLRs 2, 3, and 6–9 in papillary
dermis (a) reticular dermis (b), and epidermis (c) in comparison with normal skin, and a schematic model illustrating the increased TLR expression at
keloid scar-defined sites (d). Paraffin-embedded tissues for keloid (n¼ 9) and normal skin (n¼7) were sectioned at 5mm, dewaxed, and dehydrated.
TLRs antigens were then detected using fluorescence: Alexa 488/564 (Invitrogen, Paisley, UK). Images were captured using a light microscope (Olympus,
Essex, UK). Morphometric analysis was performed for epidermis, papillary, and reticular dermis in three random fields using Image J software (version1.42).
Statistical significance was calculated using independent t-test. Error bars represent mean±SEM. *Pp0.05 and **Pp0.01. AU, arbitrary units; pap.,
papillary; ret., reticular.
Abbreviations: KS, keloid scar; QRT-PCR, quantitative real-time RT-PCR; TLR, Toll-like receptor
speculated that KS might be induced
by viral infection (Alonso et al., 2008);
nonetheless, there is no experimental
evidence in support of this hypothesis.
A previous attempt at identifying viral
DNA directly in KS was unsuccessful,
as it failed to identify human herpesvirus-8
or Epstein–Barr virus DNA in seven
keloid cases (Pantanowitz and Duke,
2008). However, it is possible that the
experimental technique employed in
this study was neither sensitive nor
searched for the appropriate viral
particle. Thus, not knowing the identity
of the viral agent, we have approached
this question using an alternative ap-
proach.
In this pilot study, we asked whether
any evidence could be identified that
points to a viral encounter by the skin
immune system in KS. To this end, we
specifically investigated the in situ
expression of Toll-like receptors (TLRs)
known to recognize single- or double-
stranded viral particles, i.e., TLRs 2, 3,
and 6-9 (Delaloye et al., 2009; O’Neill
and Bowie, 2010) by fluorescence and
assessed by quantitative immunohisto-
morphometry (Kloepper et al., 2009).
These expressions were followed-up
by quantitative real-time RT-PCR
(QRT-PCR; see Supplementary Table
S1 online for primer sequences and
gene bank accession numbers). The
expression of these TLRs was compared
with carefully defined sites (Supplemen-
tary Figure S1 online) within and
immediately outside the keloid lesion
(‘‘intralesional’’: core of keloid, ‘‘perile-
sional’’: keloid’s margin, and ‘‘extrale-
sional’’: normal uninvolved skin adjacent
to KSs), obtained from 13 KS patients
(see demographic data in Supplementary
Table S2 online). This was compared
with normal skin (nine patients) from the
vicinity of a normal scar (patients with no
history of raised scarring).
As shown in Figure 1a and b,
immunoreactivity for TLR-8 was signifi-
cantly increased (Po0.05) in intra- and
perilesional sites of KS (see Supplemen-
tary Figure S2 online for representative
images) relative to normal dermis.
The increased intensity of TLR-8
immunoreactivity was associated with
scattered positive cells within the intra-
and perilesional sites of KS, whereas no
TLR-positive cells were observed in
extralesional KS or normal skin (Supple-
mentary Table S3 online). This protein
expression pattern corresponded well
with the substantial upregulation in
the TLR-8 mRNA in intra- and perile-
sional sites of KS, as measured by QRT-
PCR with 4.2- and 2.1-fold change,
respectively, relative to normal skin
(Figure 2). Although there was no
obvious increase in TLR-8 protein ex-
pression in situ in extralesional skin of
KS patients (Figure 1a and b), transcrip-
tion of TLR-8 was increased by 2.5-fold
change compared with normal control
skin (Figure 2).
With respect to the immunoreac-
tivity of TLR-2, -3, -6, -7, and -9, no
significant immunoreactivity differ-
ences were observed in the dermis
of KS lesion compared with control
dermis (Figure 1a and b; and Supple-
mentary Figure S2 online). The trans-
cript steady-state level of TLR-9 within
the keloid lesion was significantly
upregulated (intralesional P¼ 0.02 and
perilesional P¼0.04) relative to normal
skin (Figure 2). However, TLR-9 protein
expression was not significantly chan-
ged (Figure 1a–c). TLR-6 transcription
was slightly upregulated in intralesional
sites, whereas TLR-7 transcription was
upregulated across the different keloid
lesional sites (Figure 2). There was a
significant increase in TLR-6 (P¼0.01)
and TLR-7 (Pp0.02) immunoreactivity
in situ when the epidermis only was
compared between KS and normal
control skin (Figure 1c, Supplementary
Figure S1 online). In the epidermis,
TLR-2 and TLR-3 gene expressions were
upregulated within KS, whereas the
in situ immunoreactivity was decreased
(Figures 1 and 2). The antibody speci-
ficity of TLRs 6–8 was also confirmed
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Figure 2. Toll-like receptor (TLR) transcription in keloid scar. Fold change of transcripts of TLRs 2, 3,
and 6–9 in keloid scar (KS)-defined lesional sites relative to normal skin (a) and a schematic model
illustrating the increased TLR expression at KS-defined sites (b). Primers for TLRs were designed by and
purchased from Roche Diagnostics, West Sussex, UK (Supplementary Table S1 online). mRNA was
extracted from full-thickness tissue derived from defined KS sites (n¼ 7) and normal skin (n¼ 7).
In all, 2 mg of mRNA was reverse transcribed and quantitative real-time RT-PCR reactions were
carried out. The cycle threshold (Ct) values were normalized to the geometric mean of two housekeeping
genes (SDHA (succinate dehydrogenase complex subunit A) and RPL32 (60S ribosomal protein L32))
and analyzed by fold change (2DDCT) relative to normal skin. Error bars represent mean±SEM.
*Po0.05 and **Pp0.01.
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by using the corresponding blocking
peptide for each TLR (Supplementary
Figure S4 online).
As these findings suggest a heigh-
tened responsiveness of the skin
innate immune system toward classical
viral infection-associated TLR ligands
(Delaloye et al., 2009; O’Neill and
Bowie, 2010), this preliminary study
offers indirect support for the viral
hypothesis of KS pathogenesis (Alonso
et al., 2008).
The increased epidermal protein
expression for TLR-6 and -7 in KS is
noteworthy, as keloid keratinocytes
may have a role in stimulating keloid
fibroblast activity (Lim et al., 2002).
Although a previous study has failed
to demonstrate TLR-7 expression in
normal human keratinocytes (Lebre
et al., 2006), TLR-7 expression has
recently been detected in normal and
virally infected human keratinocytes
(Ku et al., 2008). This is well in line
with our current results. The markedly
increased upregulation of the TLR-8
gene and protein levels in keloid dermis
may reflect the possible encounter of
intradermal immunocytes, such as
dermal dendrocytes, and/or macro-
phages with virus-associated ligands
(Heydtmann, 2009). Viruses such as
influenza virus, parechovirus 1, and
modified vaccinia virus Ankara have
been identified as triggers of antiviral
pathways through activation of TLRs
6–8 (Triantafilou et al., 2005; Delaloye
et al., 2009). However, it is uncertain
whether viral ligands are responsible for
the observed upregulation of TLR-6, -7,
and -8 in KS. It also remains to be
further investigated whether non-viral
ligands of TLRs 6–8 may influence
keloid etiopathogenesis by stimulating
TLR receptors. Given that viral infection
is among the most potent stimuli for
upregulating TLRs (Alonso et al., 2008;
Delaloye et al., 2009), it is reasonable
to systematically explore the involve-
ment of either viral or non-viral stimuli
in keloid pathogenesis. Existing KS
organ culture models may be utilized
to investigate whether antagonizing
TLRs 6–8-mediated signaling and/or
downregulation of these receptors may
impact on keloid progression and
resolution.
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